Home / News / India News / Article /
SC takes into account WHO report on Remdesivir, seeks Centre's response
Updated On: 29 October, 2020 06:00 PM IST | Mumbai | IANS
Remdesivir and Favipiravir are antiviral drugs and their efficacy in the treatment of Covid-19 patients is still under debate among the medical experts

Supreme Court
The Supreme Court on Thursday took into account a World Health Organisation report, indicating that Remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect in the treatment of Covid-19. The top court sought a response from the Centre on a plea alleging that Remdesivir and Favipiravir are being used without approval.
The #SupremeCourt on Thursday took into account a World Health Organisation report, indicating that Remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect in the treatment of #COVID19. pic.twitter.com/bnzVJgGARV
— IANS Tweets (@ians_india) October 29, 2020
A bench headed by Chief Justice S.A. Bobde and comprising Justices A.S. Bopanna and V. Ramasubramanian said after going through the report they noted that it is a serious matter.
Trending Stories
ADVERTISEMENT
ADVERTISEMENT


